About Us

Publications

BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: Some Publications were unable to be listed below - please see that listing here. All other publications based on PubMedIDs are listed below.

 

Found 78 results
Filters: Keyword is Hematopoietic Stem Cell Transplantation  [Clear All Filters]
2021
R. Reshef, Saber, W., Bolaños-Meade, J., Chen, G., Bin Chen, Y. -, Ho, V. T., Ponce, D. M., Nakamura, R., Martens, M. J., Hansen, J. A., and Levine, J. E., Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study., J Clin Oncol, vol. 39, no. 17, pp. 1878-1887, 2021.
R. Nakamura, Saber, W., Martens, M. J., Ramirez, A., Scott, B., Oran, B., Leifer, E., Tamari, R., Mishra, A., Maziarz, R. T., McGuirk, J., Westervelt, P., Vasu, S., Patnaik, M., Kamble, R., Forman, S. J., Sekeres, M. A., Appelbaum, F., Mendizabal, A., Logan, B., Horowitz, M., and Cutler, C., Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome., J Clin Oncol, vol. 39, no. 30, pp. 3328-3339, 2021.
H. E. Heslop, Stadtmauer, E. A., Levine, J. E., Ballen, K. K., Bin Chen, Y. -, DeZern, A. E., Eapen, M., Hamadani, M., Hamilton, B. K., Hari, P., Jones, R. J., Logan, B. R., Kean, L. S., Leifer, E. S., Locke, F. L., Maziarz, R. T., Nemecek, E. R., Pasquini, M., Phelan, R., Riches, M. L., Shaw, B. E., Walters, M. C., Foley, A., Devine, S. M., and Horowitz, M. M., Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year., Transplant Cell Ther, vol. 27, no. 11, pp. 885-907, 2021.
S. M. Devine and Horowitz, M. M., Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies., J Clin Oncol, vol. 39, no. 5, pp. 534-544, 2021.
C. G. Brunstein, DeFor, T. E., Fuchs, E. J., Karanes, C., McGuirk, J. P., Rezvani, A. R., Eapen, M., O'Donnell, P. V., and Weisdorf, D. J., Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent Patients., Transplant Cell Ther, vol. 27, no. 10, pp. 879.e1-879.e3, 2021.
N. Farhadfar, Burns, L. J., Mupfudze, T., Shaw, B. E., Bollard, C. M., Devine, S. M., Horowitz, M. M., Jones, R. J., Murthy, H. S., Wingard, J. R., and Lee, S. J., Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023., Transplant Cell Ther, vol. 27, no. 2, pp. 183.e1-183.e7, 2021.
P. Shindiapina, Pietrzak, M., Seweryn, M., McLaughlin, E., Zhang, X., Makowski, M., Ahmed, E. Hassan, Schlotter, S., Pearson, R., Kitzler, R., Mozhenkova, A., Le-Rademacher, J., Little, R. F., Akpek, G., Ayala, E., Devine, S. M., Kaplan, L. D., Noy, A., Popat, U. R., Hsu, J. W., Morris, L. E., Mendizabal, A. M., Krishnan, A., Wachsman, W., Williams, N., Sharma, N., Hofmeister, C. C., Forman, S. J., Navarro, W. H., Alvarnas, J. C., Ambinder, R. F., Lozanski, G., and Baiocchi, R. A., Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial., Front Immunol, vol. 12, p. 700045, 2021.
B. L. Scott, Pasquini, M. C., Fei, M., Fraser, R., Wu, J., Devine, S. M., Porter, D. L., Maziarz, R. T., Warlick, E., Fernandez, H. F., Soiffer, R. J., Alyea, E., Hamadani, M., Bashey, A., Giralt, S., Geller, N. L., Leifer, E., Hourigan, C. S., Gui, G., Mendizabal, A., Horowitz, M. M., H Deeg, J., and Horwitz, M. E., Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial., Transplant Cell Ther, vol. 27, no. 6, pp. 483.e1-483.e6, 2021.
H. T. Kim, Logan, B., and Weisdorf, D. J., Novel Composite Endpoints after Allogeneic Hematopoietic Cell Transplantation., Transplant Cell Ther, vol. 27, no. 8, pp. 650-657, 2021.
2020
O. Shah, Tamaresis, J. S., Kenyon, L. Jean, Xu, L., Zheng, P., Gupta, P., Rangarajan, K., Lee, S., Spellman, S., Nikiforow, S., Zehnder, J., and Meyer, E. H., Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts., Biol Blood Marrow Transplant, vol. 26, no. 6, pp. 1050-1070, 2020.
L. F. Newell, DeFor, T. E., Cutler, C., Verneris, M. R., Blazar, B. R., Miller, J. S., Antin, J. H., Howard, A., Wu, J., MacMillan, M. L., Panoskaltsis-Mortari, A., Weisdorf, D. J., and Holtan, S. G., Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation., Biol Blood Marrow Transplant, vol. 26, no. 3, pp. 606-611, 2020.
C. S. Hourigan, Dillon, L. W., Gui, G., Logan, B. R., Fei, M., Ghannam, J., Li, Y., Licon, A., Alyea, E. P., Bashey, A., H Deeg, J., Devine, S. M., Fernandez, H. F., Giralt, S., Hamadani, M., Howard, A., Maziarz, R. T., Porter, D. L., Scott, B. L., Warlick, E. D., Pasquini, M. C., and Horwitz, M. E., Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease., J Clin Oncol, vol. 38, no. 12, pp. 1273-1283, 2020.
L. J. Costa, Iacobelli, S., Pasquini, M. C., Modi, R., Giaccone, L., Blade, J., Schonland, S., Evangelista, A., Perez-Simon, J. A., Hari, P., Brown, E. E., Giralt, S. A., Patriarca, F., Stadtmauer, E. A., Rosinol, L., Krishnan, A. Y., Gahrton, G., and Bruno, B., Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation., Bone Marrow Transplant, vol. 55, no. 9, pp. 1810-1816, 2020.
Z. DeFilipp, Burns, L. J., Jaglowski, S. M., Leppin, A. L., Pavletic, S., Waldman, B., Weisdorf, D. J., Wood, W. A., and Khera, N., A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703., Biol Blood Marrow Transplant, vol. 26, no. 12, pp. e305-e308, 2020.
J. E. Levine, Antin, J. H., Allen, C. E., Burroughs, L. M., Cooke, K. R., Devine, S., Heslop, H., Nakamura, R., Talano, J. An, Yanik, G., and DiFronzo, N., Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network., Biol Blood Marrow Transplant, vol. 26, no. 5, pp. e94-e100, 2020.
S. Giralt, Costa, L. J., Maloney, D., Krishnan, A., Fei, M., Antin, J. H., Brunstein, C., Geller, N., Goodman, S., Hari, P., Logan, B., Lowsky, R., Qazilbash, M. H., Sahebi, F., Somlo, G., Rowley, S., Vogl, D. T., Vesole, D. H., Pasquini, M., and Stadtmauer, E., Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial., Biol Blood Marrow Transplant, vol. 26, no. 4, pp. 798-804, 2020.
2019
R. F. Ambinder, Wu, J., Logan, B., Durand, C. M., Shields, R., Popat, U. R., Little, R. F., McMahon, D. K., Cyktor, J., Mellors, J. W., Ayala, E., Kaplan, L. D., Noy, A., Jones, R. J., Howard, A., Forman, S. J., Porter, D., Arce-Lara, C., Shaughnessy, P., Sproat, L., Hashmi, S. K., Mendizabal, A. M., Horowitz, M. M., Navarro, W. H., and Alvarnas, J. C., Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial., Biol Blood Marrow Transplant, vol. 25, no. 11, pp. 2160-2166, 2019.
E. A. Stadtmauer, Pasquini, M. C., Blackwell, B., Hari, P., Bashey, A., Devine, S., Efebera, Y., Ganguly, S., Gasparetto, C., Geller, N., Horowitz, M. M., Koreth, J., Knust, K., Landau, H., Brunstein, C., McCarthy, P., Nelson, C., Qazilbash, M. H., Shah, N., Vesole, D. H., Vij, R., Vogl, D. T., Giralt, S., Somlo, G., and Krishnan, A., Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial., J Clin Oncol, vol. 37, no. 7, pp. 589-597, 2019.
J. Paul, Nakasone, H., Sahaf, B., Wu, F., Wang, K., Ho, V., Wu, J., Kim, H., Blazar, B., Ritz, J., Howard, A., Cutler, C., and Miklos, D., A confirmation of chronic graft--host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation., Haematologica, vol. 104, no. 7, pp. e314-e317, 2019.
M. Gooptu, Kim, H. T., Howard, A., Choi, S. W., Soiffer, R. J., Antin, J. H., Ritz, J., and Cutler, C. S., Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clini, Biol Blood Marrow Transplant, vol. 25, no. 11, pp. 2143-2151, 2019.
M. J. Levis, Bin Chen, Y. -, Hamadani, M., Horowitz, M. M., and Jones, R. J., FLT3 Inhibitor Maintenance After Allogeneic Transplantation: Is a Placebo-Controlled, Randomized Trial Ethical?, J Clin Oncol, vol. 37, no. 19, pp. 1604-1607, 2019.
A. A. King, McKinstry, R. C., Wu, J., Eapen, M., Abel, R., Varughese, T., Kamani, N., and Shenoy, S., Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601., Biol Blood Marrow Transplant, vol. 25, no. 5, pp. e174-e178, 2019.